OPEN END TURBO LONG - HALEON Stock

Certificat

DE000MD7LM24

Market Closed - Börse Stuttgart 07:03:54 2024-06-13 am EDT
0.71 EUR 0.00% Intraday chart for OPEN END TURBO LONG - HALEON
Current month-5.33%
1 month-7.79%

Comparison chart between the derivative product and it's underlying value

End-of-day quotes
Date Price Change
24-06-13 0.71 0.00%
24-06-12 0.71 -1.39%
24-06-11 0.72 -5.26%
24-06-10 0.76 -7.32%
24-06-07 0.82 -1.20%

Delayed Quote Börse Stuttgart

Last update June 13, 2024 at 07:03 am EDT

More quotes

Static data

Product typeKnock-Out without Stop Loss
Buy / SellCALL
Underlying HALEON PLC
Issuer Morgan Stanley
WKN MD7LM2
ISINDE000MD7LM24
Date issued 2022-08-30
Strike 261.1 p
Maturity Unlimited
Parity 1 : 1
Emission price 0.44
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 1.33
Lowest since issue 0.152

Company Profile

Haleon plc specializes in the research, manufacture and marketing of drugs and consumer pharmaceutical products. Net sales break down by family of products as follows: - oral health products (27.7%; no. 1 worldwide): Sensodyne, Parodontax, Polident, Biotene, Aquafresh brands, etc.; - Pain relief medicines (23.5%; no. 1 worldwide): Panadol, Advil, Voltaren, Excedrin brands, etc.; - medicines for digestive health (18.9%; no. 1 worldwide): TUMS, Nicorette, ENO, Chap Stick, Fenistil, Nexium brands, etc.; - respiratory medicines (15.4%; no. 1 worldwide): Theraflu, Otrivin, Flonase, Contac brands, etc.; - vitamins, minerals and food supplements (14.5%; no. 1 worldwide): Centrum, Emergen-C, Caltrate brands, etc. Net sales are distributed geographically as follows: Europe/Middle East/Africa/Latin America (40.2%), North America (37.1%), and Asia/Pacific (22.7%).
Sector
-
More about the company

Ratings for Haleon plc

Trading Rating
Investor Rating
ESG Refinitiv
B
More Ratings

Consensus: Haleon plc

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
18
Last Close Price
3.258 GBP
Average target price
3.646 GBP
Spread / Average Target
+11.92%
Consensus